STRATµM Trademark

Trademark Overview


On Tuesday, August 23, 2022, a trademark application was filed for STRATµM with the United States Patent and Trademark Office. The USPTO has given the STRATµM trademark a serial number of 97559973. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by Adare Pharmaceuticals USA, Inc.. The STRATµM trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery

Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery
stratµm

General Information


Serial Number97559973
Word MarkSTRATµM
Filing DateTuesday, August 23, 2022
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7068545
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesManufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery
Goods and ServicesPharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code040
First Use Anywhere DateFriday, August 22, 2014
First Use In Commerce DateFriday, August 22, 2014

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code042
First Use Anywhere DateFriday, August 22, 2014
First Use In Commerce DateFriday, August 22, 2014

Trademark Owner History


Party NameAdare Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameAdare Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameAdare Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 6, 2023ASSIGNED TO EXAMINER
Monday, September 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 26, 2022NEW APPLICATION ENTERED